Argyle Capital Management’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
Argyle Capital Management's OGN Position: Q3 2022 in Review
Argyle Capital Management sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 7,462 shares — an estimated $252K sold.
Argyle Capital Management first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $268K in Q3 2021. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.
- Argyle Capital Management reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
- Argyle Capital Management sold 7,462 Organon & Co shares in Q3 2022, an estimated $252K.
- Argyle Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
- Argyle Capital Management's Organon & Co position peaked at $268K in Q3 2021.
- 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.
Based on Argyle Capital Management's 13F filing for Q3 2022, filed 21 Oct 2022.